DS-7080a
/ Daiichi Sankyo
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 04, 2020
DS-7080a, a Selective Anti-ROBO4 Antibody, Shows Anti-Angiogenic Efficacy with Distinctly Different Profiles from Anti-VEGF Agents.
(PubMed, Transl Vis Sci Technol)
- "Further, HUVEC migration induced by HRPE-conditioned medium was inhibited by either DS-7080a or ranibizumab in a similar manner, and the combination of these showed further inhibition. Anti-ROBO4 antibody DS-7080a suppressed HUVEC migration in a distinctly different fashion from anti-VEGF agents and improved laser-induced CNV in non-human primates. DS-7080a may be a novel treatment option for nAMD."
Clinical • Journal • Age-related Macular Degeneration • Complement-mediated Rare Disorders • Macular Degeneration • Ophthalmology • Retinal Disorders • Wet Age-related Macular Degeneration • FGF • HGF
1 to 1
Of
1
Go to page
1